Guidelines for Evaluating an Essential Drugs Programme
(64 pages) View the PDF document
Table of Contents
View the documentINTRODUCTION
View the documentPROCEDURES FOR EVALUATION OF AN ACTION PROGRAMME ON ESSENTIAL DRUGS (APED)
View the documentEXECUTIVE SUMMARY: OVERALL CONCLUSIONS AND RECOMMENDATIONS
View the document1. SUMMARY BACKGROUND INFORMATION ON COUNTRY AND HEALTH CARE SYSTEM1
View the document2. BRIEF DESCRIPTION OF THE GENERAL FEATURES OF THE APED PROGRAMME
View the document3. ECONOMIC AND SOCIOECONOMIC ASPECTS OF THE APED PROGRAMME
Close this folder4. ANALYSIS OF EFFICIENCY
Open this folder and view contents4.1 SELECTION
Close this folder4.2 LOGISTICS
Close this folder4.2.1 PROCUREMENT
View the documentA. PROCUREMENT METHOD
View the documentB. CONTRACT TERMS
View the documentC. LOCATING AND SELECTING SUPPLIERS
View the documentD. PROCURING
View the documentE. MONITORING SUPPLIER PERFORMANCE
View the documentF. QUALITY ASSURANCE
View the documentG. LOCAL PRODUCTION OF PHARMACEUTICALS OR IMPORT
Open this folder and view contents4.2.2 DISTRIBUTION
Open this folder and view contents4.2.3 LOGISTIC SUPPORT
Open this folder and view contents4.3 MANPOWER DEVELOPMENT
View the document4.4 HEALTH EDUCATION AND INFORMATION
Open this folder and view contents4.5 POLICY AND LEGAL ASPECTS
Open this folder and view contents5. ASSESSMENT OF EFFECTIVENESS
Open this folder and view contents6. MANAGING THE ESSENTIAL DRUG PROGRAMME
Open this folder and view contents7. ASSESSMENT OF INPUTS OF THE GOVERNMENT AND DONORS
Open this folder and view contents8. PLANNING FOR THE FUTURE
View the document9. REFERENCES
Open this folder and view contentsMANUAL FOR CONDUCTING AN EVALUATION OF AIM ACTION PROGRAMME ON ESSENTIAL DRUGS (APED)
 
G. LOCAL PRODUCTION OF PHARMACEUTICALS OR IMPORT

a) Describe the local pharmaceutical production capability doing:

- primary manufacturing (the production of active medicinal substances and other ancillary substances used in pharmaceutical formulations);

- secondary manufacturing (the processing of medicinal substances, usually together with ancillary substances, to produce the required pharmaceutical dosage forms);

- packaging (the packaging of dosage forms in manners appropriate to the nature of the preparations and their intended use, conditions of transportation, and expected conditions and time of storage).


and assess the potential for the future (Does government policy promote local production?).

b) Are locally-produced drugs essential?

c) Assess whether locally-produced drugs are competitive with similar drugs on the international market?

to previous section to next section
 

Last updated: May 3, 2013